Ep151: Shelley Force Aldred and Nathan Trinklein on Bispecific Antibodies for Cancer
The Long Run with Luke Timmerman - A podcast by Timmerman Report
Shelley Force Aldred and Nathan Trinklein, co-founders of Rondo Therapeutics, on the opportunity with bispecific antibodies for cancer.
